ABSTRACT
increasing mitochondrial biogenesis and improving function in heart failure, we used a 23 mouse model of moderate overexpression of PGC1α (~3-folds) in the heart (TG). TG 
50
plays an important role in the development and progression of heart failure (10).
51
Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC1α) has 
59
Several attempts have been made over the last several years to enhance mitochondrial 60 biogenesis in the heart by overexpressing PGC1α but the outcomes were not as 61 promising as anticipated. Lehman et. al. (14) showed that cardiac overexpression of
62
PGC1α results in a progressive and uncontrolled increase in mitochondrial number that 63 disrupts the cardiomyocyte sarcomeric structure leading to contractile dysfunction.
64
Similarly, using an inducible model of PGC1α overexpression, Russell et. al. (23) 
71
of PGC1α in pathological cardiac hypertrophy and heart failure has not been tested.
72
In this study, we examined whether a mild upregulation of PGC1α could maintain 73 mitochondrial biogenesis and preserve cardiac function during chronic cardiac stress.
74
We found that cardiac mitochondrial morphology and function were maintained in a 75 mouse model overexpressing PGC1α by 3-fold in the heart. Although the expression of 76 genes involved in mitochondrial biogenesis in TG mice after chronic pressure overload 77 was maintained at a level similar to that in WT-Sham, cardiac function and long term 78 survival of the mice were not improved.
80
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MATERIALS AND METHODS

81
Animal experiments
82
All animal experiments were performed with the approval of the Institutional Animal Care 
113
Transverse aortic constriction surgery
114
Eight and sixteen week old mice underwent transverse aortic constriction (TAC) or sham 115 surgery as previously described (7, 25 
138
are presented as mean fold changes relative to the respective WT-sham-operated mice.
139
Mitochondrial isolation and polarography assays
140
Mitochondria were isolated as previously described (3). Oxygen consumption of isolated 141 mitochondria was measured by a Clark electrode as described (13) . Pyruvate and 142 malate were used as the electron donors to complex I in the presence of ADP. Succinate
143
was next added to measure complex I and II supported respiration and rotenone was 144 added next to inhibit complex I and measure complex II supported respiration. Antimycin
145
A was added last to measure the residual oxygen consumption not accounted by the 146 electron transfer chain and it was subtracted from the previous measurements.
147
Biochemical assays
148
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Enzyme activities were measured in isolated mitochondria solubilized in CelLytic buffer 149 (Sigma). Citrate synthase (CS) activity and succinate dehydrogenase were measured as 150 previously described (11, 22, 27) .
151
Detection of H 2 O 2 production
152
The rate of H 2 O 2 production in intact mitochondria was determined using the oxidation of 
157
Electron microscopy
158
Mitochondrial ultrastructure was studied in freshly collected LV tissues by electron 159 microscopy. Samples were dissected in 1-to 2mm 3 sections and immediately fixed with
160
2% glutaraldehyde, postfixed with 1% osmium tetroxide, and embedded in epon resin.
161
For each sample, 5-6 randomly chosen fields at the magnification of x10000 were used 162 for the quantification of the mitochondria number. The size of each individual 163 mitochondrion was measured in the same micrographs using the Image J software.
164
Statistical analysis
165
Comparisons among groups were performed by 1-way ANOVA, followed by Tukey's 166 post hoc comparisons. Data from the isolated perfused heart experiments were
167
analyzed by a repeated measures ANOVA followed by Bonferroni's post-hoc analysis.
168
Kaplan-Meier survival curves were compared using the log-rank test (Mantel-Cox test).
169
Hazard ratio for mortality was determined using the Mantel-Haenszel analysis and
170
presented as hazard ratio with 95% CIs. All analyses were performed using GraphPad 
173
PGC1α overexpression in the heart increased mitochondrial size.
176
To test the effects of PGC1α-mediated mitochondrial biogenesis as a potential 177 therapeutic approach for mitochondrial dysfunction and heart failure, we studied a 
196
To determine whether the overexpression of PGC1α altered mitochondrial function, we 197 measured oxygen consumption in isolated cardiac mitochondria using a Clark electrode. and TG in any of the conditions we tested ( Figure 3B ). 
212
To determine whether increasing PGC1α expression affected myocardial ATP 213 production, we measured high-energy phosphate content in isolated perfused hearts 214 using 31 P NMR spectroscopy both at baseline and during a high workload challenge.
215
During the high workload challenge, the calcium concentration in the perfusate was 
224
Coronary flow was significantly increased to a similar degree in both WT and TG hearts
225
( Figure 4F ). No significant differences were observed in PCr, ATP, or Pi during the high 226 workload challenge ( Figure 4G-I ). These data demonstrate that a moderate 227 overexpression of PGC1α does not offer any functional or energetic advantage to hearts 228 at normal or high workload conditions.
229
Acute mortality was increased in PGC1α TG mice subjected to pressure overload.
230
To determine whether overexpression of PGC1α protected the heart from pressure 231 overload induced hypertrophy and failure, we subjected 16-week old TG and WT mice to
232
sham or transverse aortic constriction (TAC) surgery. Interestingly, we observed a 233 significantly higher acute mortality in both male and female TG mice after TAC ( Figure   234 5A-B), while there was minimal acute mortality after sham surgery for either genotype
235
(data not shown). Approximately 70% male and 45% female TG mice died within 2 hours
236
of TAC surgery compared to 30% male and 10% female WT mice died during the same 237 period. We subsequently performed surgery in a cohort of younger mice (8-week old).
238
The acute mortality of the 8-week old WT mice subjected to TAC surgery was similar as 
242
compromised the acute responses to stress. Despite the differences in acute mortality,
243
there was no difference in the chronic survival of WT and TG mice in the 8 weeks after
244
TAC surgery for both males and females.
245
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Cardiac function was not improved in TG mice despite the normalization of 246 mitochondrial biogenesis in pressure overload induced cardiac hypertrophy.
247
TAC induced a significant and similar increase in the LV posterior wall thickness in WT
248
and TG mice at 2 weeks, which persisted throughout the 8-week period ( Figure 6A ). The
249
LV chamber dimension was similar before surgery but increased progressively after TAC
250
in the TG but not in the WT mice ( Figure 6B ). The LV fractional shortening (FS) also
251
showed a greater decline in the TG mice after TAC compared to WT ( Figure 6C ).
252
Furthermore, both lung and heart weights were increased 8 weeks after TAC, consistent
253
with the echocardiographic results of cardiac hypertrophy and LV dysfunction ( Figure   254 6D-E). PGC1α expression remained elevated in the TG TAC mice compared to WT TAC
255
( Figure 6F ). In mice subjected to TAC at 8 weeks of age, a mild LV dysfunction was 256 observed and there was no difference between the two genotypes ( Figure 7 ).
257
To assess whether PGC1α overexpression sustained mitochondrial biogenesis during 
265
was moderately decreased in WT mice subjected to TAC ( Figure 8E ). In the TG sham 266 mice, the expression of these genes was 20-30% higher, and after TAC it was 267 normalized to the WT-Sham levels. The activity of citrate synthase, a mitochondrial 268 matrix enzyme often used as a marker of mitochondrial mass, was slightly higher in the
269
TG-sham and remained higher in TG-TAC compared to WT-TAC ( Figure 8D ). Taken
PGC1α overexpression in cardiac pressure overload 13 that PGC1α/β deletion is detrimental during development but not in adult hearts (17).
322
Deletion of both PGC1α/β leads to lethal cardiomyopathy whereas deletion of both
323
isoforms in adulthood appears to be well tolerated at least in non-stressed conditions.
324
This suggests that mitochondrial biogenesis in the adult heart may be controlled by an 325 additional mechanism that is activated after maturation. It may also explain why modest
326
PGC1α overexpression does not have a major effect in cardiac mitochondrial volume or 327 mass in our study.
328
Interestingly, despite the unimpressive effects on mitochondrial biogenesis, long term 
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In this study we found that the survival rate was higher in female than male mice for both 345 phenotypes in response to pressure overload. This is consistent with the reported sex 346 differences in the cardiac responses to stress. Male mice have been shown to be more 347 susceptible to the development of pressure overload induced cardiac hypertrophy and 348 cardiac ischemia/reperfusion injury (5, 6, 24). Furthermore, the prevalence of 349 cardiovascular disease and heart failure in pre-menopausal women is lower compared to 350 men and this has been attributed primarily to hormonal differences (9). It is also possible 351 that the degree of constriction resulted from the ligation against a 28G needle is more
352
severe for the male mice that are ~20% larger than age-matched females. Nevertheless,
353
within the same sex, the transgenic mice consistently presented a higher mortality
354
suggeting that the detrimental effects of PGC1α overexpression are not sex-specific.
355
In summary, the study assessed whether a moderate level of 
474
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541
The mRNA levels of (A) brain natriuretic peptide (Bnp), (B 
